TAMPA, FL--(Marketwire - February 11, 2009) - Today Transfer Technology International Corp. (PINKSHEETS: TTIN) signed an agreement appointing Dr. David M. Silver as a member of the Scientific Advisory Board. Dr. Silver comes to TTI with an extremely strong background and track record in the technology sector. Dr. Silver is currently Senior Scientist at the Johns Hopkins University Applied Physics Laboratory. His research has spanned molecular physics, submarines, atmospheric chemistry, spacecraft, and ophthalmology. He has published widely in the scientific and medical journals, has been co-inventor on three patents, and has been instrumental in developing new technology and bringing it to the marketplace.
Dr. Silver’s academic credentials include a B.S. from Illinois Institute of Technology, an M.A. from Johns Hopkins University, a Ph.D. from Iowa State University, and postdoctoral positions at Harvard University and the University of Paris. Along the way, he had been named the Dunning Professor of Ophthalmology at the Wilmer Eye Institute (1998-99) and Visiting Professor in Ophthalmology at the University of Debrecen, Hungary (2001). In addition, he has been a director of two public companies in the medical product sector.
Christoph A. Trina, Chairman and CEO, states, “With his talent, background, and broad interests, Dr. Silver brings additional credibility and visibility to our company. I truly believe that David will complement our existing Advisory Board with his technical insights and commercial experience to help make our company a major player in the ever growing technology transfer market.”
Dr. Silver states, “Transfer Technology is an exciting venture with great opportunities available for discovering technological innovation and developing it into a marketable product. With the dynamic leadership of Ms. Valerie McDevitt, the Advisory Board’s Director, I am confident that we can move forward, identify new ideas and projects, and transform them into business enterprises.”
Please visit us at our new website, www.ttinternationalcorp.com, for more information. You will be able to find our SEC filings, press releases, our stock quote and corporate updates.
About Transfer Technology International Corp. (PINKSHEETS: TTIN)
The company was formulated on the premise of acquiring, procuring and funding of current technologies, research and intellectual properties for the transference of these technologies for commercialization. We anticipate generating revenue from a variety of methods including transfer fees, licensing and strategic alliance fees and the sale of intellectual properties.
Disclaimer and Forward-Looking Statements -- The information contained herein regarding risks and uncertainties, which may differ materially from those set forth in these statements, in addition to the economic, competitive, governmental, technological and other factors, constitutes a “forward-looking statement” within the meaning of Section 27A of The Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 and is subject to the safe harbors created thereby. While the company believes that the assumptions underlying such forward-looking information are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the forward-looking information will prove to be accurate. Accordingly, there may be differences between the actual results and the predicted results, and actual results may be materially higher or lower than those indicated in the forward-looking information contained herein.
Contact for Investors:
Mr. Christoph A. Trina
Chairman and CEO
813-600-4081
